TORONTO (CP) - The maker of an attention deficit hyperactivity disorder drug forced off the market last month by Health Canada signalled Wednesday it has triggered a review process aimed at getting the regulator to let sales of the drug resume....More
Thursday, March 03, 2005
Subscribe to:
Post Comments (Atom)
Posts
No comments:
Post a Comment